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The tumor suppressor protein p53 is a key regulator of cell cycle arrest and apoptosis. Snail protein
regulates cancer-associated malignancies. However, the relationship between p53 and Snail pro-
teins in hepatocellular carcinoma (HCC) has not been completely understood. To determine whether
Snail and p53 contribute to hepatocarcinogenesis, we analyzed the expression of Snail proteins in
p53-overexpressing HCC cells. We found that p53 wild-type (WT) induced the degradation of Snail
protein via murine double minute 2-mediated ubiquitination, whereas p53 mutant did not induce
Snail degradation. As we expected, only p53WT induced endogenous Snail protein degradation and
inhibited tumor cell invasion. These ﬁndings contribute to a better understanding of the role of p53
mutation and Snail overexpression as a late event in hepatocarcinogenesis.
Structured summary:
MINT-7718917: p53 (uniprotkb:P04637) physically interacts (MI:0915) with Snai1 (uniprotkb:O95863) by
anti bait coimmunoprecipitation (MI:0006)
MINT-7719877: Snai1 (uniprotkb:O95863) physically interacts (MI:0915) with ubiquitin (uni-
protkb:P62988) by anti tag coimmunoprecipitation (MI:0007)
MINT-7718928: Snai1 (uniprotkb:O95863) physically interacts (MI:0915) with p53 (uniprotkb:P04637) by
anti tag coimmunoprecipitation (MI:0007)
MINT-7718939: Snai1 (uniprotkb:O95863) physically interacts (MI:0915) with MDM2 (uni-
protkb:Q00987) by anti tag coimmunoprecipitation (MI:0007)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction mechanisms of HCC is critical for identifying potential therapeuticHepatocellular carcinoma (HCC) is a common and highly inva-
sive malignant tumor with a very high mortality rate [1,2]. The
existing antineoplastic agents are ineffective against HCC. Further,
the applicability of chemotherapy for HCC is limited by the pres-
ence of underlying liver disease. As a result, HCC patients have a
poor prognosis [3]. Although surgical resection is effective and is
the preferred standard treatment for the management of HCC pa-
tients, few patients are suitable candidates for this treatment,
and recurrence is common even after radical curative resection
[3,4]. Considering the inadequate impact of conventional therapies
and the rising incidence of HCC, elucidation of the oncogenicchemical Societies. Published by E
M2, murine double minute 2;
esenchymal transition; WT,
EF, mouse embryo ﬁbroblast
f Biological Sciences, Seoul
. Fax: +82 2 872 1993.targets and modalities.
We have previously reported that aberrant expression of Snail
via activation of reactive oxygen species partly contributes to the
invasive properties of HCC, which are mediated by the induction
of matrix metalloproteinases (MMPs) and downregulation of
E-cadherin through both transcriptional repression and epigenetic
modiﬁcation of its promoter [5]. Snail has been identiﬁed as the
zinc ﬁnger transcriptional repressor responsible for epithelial-to-
mesenchymal transitions (EMTs) and metastasis in several cancers
[6,7]. Recent studies have also revealed the role of Snail, indepen-
dent of its DNA-binding properties, in inducing broad epigenetic
modiﬁcations of target genes through interaction with tumor-asso-
ciated proteins, including HDAC1, DNMT1, and p53 [5,8–10]. These
ﬁndings suggest that the ability of Snail to promote oncogenic
transformation and cancer cell invasion may be partly mediated
by direct interaction with its binding partners.
The tumor suppressor p53 is a key regulator of cell cycle arrest
and apoptosis [11]. Its activity and stability are regulated by alsevier B.V. All rights reserved.
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lar interactions inﬂuenced by several signaling pathways A muta-
tion in the p53 gene causes p53 inactivation in 50% of human
cancers [12]. Wild-type (WT) p53 is also inactivated by regulators
such as the ubiquitin ligase murine double minute 2 (MDM2) [13].
In humans, reactivation of p53WT in tumor cells has been consid-
ered as a potential cancer therapy; this ﬁnding has stimulated the
search for a new class of reagents with p53-like activity [13]. A bet-
ter understanding of the molecular mechanisms of p53 function is
required for the development of optimal treatment strategies.
The Twist protein, a member of the Snail family, can inhibit p53
transcription by direct interaction with its DNA-binding domain;
this ﬁnding indicates the involvement of the Snail pathway in
p53 function [14]. Oncogenic K-Ras was also shown to abrogate
p53 function by promoting p53-Snail binding [9]. These results
suggest an oncogenic link between the p53 and Snail pathways.
In this study, we show that an interaction between Snail and
p53 speciﬁcally induces Snail degradation and inhibits Snail-
dependent functions such as tumor cell invasion in HCC. Our re-
sults suggest the presence of an additional mechanism by which
the p53/Snail interaction regulates tumor cell invasion. We also
show that p53WT inhibits tumor cell invasion by inducing
MDM2-mediated Snail degradation.
2. Materials and methods
2.1. Cell culture and treatments
Hep3B (human hepatoma cells), Huh7 (human hepatoma cells),
HepG2 (human hepatoblastoma cells), and 293T cells were cul-Fig. 1. p53 induces Snail degradation. (A) Snail interacts with endogenous p53 protein. T
Flag and anti-p53 antibodies, and analyzed by immunoblotting. IgG served as a negative
mutant (Mut), and/or HA-Snail, followed by immunoblot analysis of Myc-p53 and HA-Sn
transfected with Myc-p53WT, Myc-p53Mut, and/or HA-Snail, and the Myc-p53 and HA-S
do not reduce Snail protein expression. Hep3B cells were transfected with Myc-p53WT, M
Snail expression. The R72P mutant, which occurs in the p53 transactivation domain and
served as an internal control.tured in Dulbecco’s modiﬁed Eagle’s medium (DMEM) with 10% fe-
tal bovine serum (FBS). In some experiments, the cells were
incubated for 6 h with 10 lM Nutlin-3. Primary mouse embryonic
ﬁbroblasts (MEFs) were obtained from 13.5-day-old mice embryos
and were cultured in DMEM medium supplemented with 10% FBS.
For siRNA experiments, the cells were transfected with p53 siRNA,
MDM2 siRNA, and control siRNA (ON-TARGETplus siRNA
reagents; Dharmacon, Lafayette, CO, USA) using Oligofectamine
reagents (Invitrogen, Carlsbad, CA, USA). Snail protein expression
was analyzed by immunoblotting, which was performed 72 h after
transfection. All other reagents were purchased from Sigma (St.
Louis, MO, USA).
2.2. Immunoblot analysis and immunoprecipitation
Tissue and cell lysates were prepared and immunoblot analysis
was performed according to a protocol described elsewhere [15].
For immunoprecipitation analysis, Hep3B cells were transfected
with Flag-Snail and MDM2. After 48 h, the cells were lysed in a ly-
sis buffer [50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 5 mM EDTA,
0.5% NP-40], and the lysates were centrifuged at 16 000g for
15 min to remove debris. The cleared lysates were subjected to
immunoprecipitation with antibodies.
2.3. Proliferation and invasion assays
Cell proliferation was measured at 24-h intervals for a duration
of 72 h according to the manufacturer’s instructions (Cell counting
kit-8 (CCK-8) assay kit; Dojindo Laboratories, Kumamoto, Japan).
Cell invasion wasmeasured at 96 h according to the manufacturer’she 293T cells were transfected with Flag-Snail, co-immunoprecipitated using anti-
control. (B) Hep3B cells were transfected with Myc-p53 wild-type (WT), Myc-p53
ail. (C) Overexpressed p53WT does not inhibit Snail transcription. Hep3B cells were
nail transcript levels were analyzed by real-time RT-PCR. (D) p53 DBD point mutants
yc-p53Mut, and/or HA-Snail, followed by immunoblot analysis of Myc-p53 and HA-
has the same phenotype as p53WT, served as the positive control [23], and b-actin
S.-O. Lim et al. / FEBS Letters 584 (2010) 2231–2236 2233instructions (Oris™ Cell invasion and detection assay kit; Platypus
Technologies, LLC, Fitchburg, WI, USA). In the invasion assay, ﬂuo-
rescence was monitored at excitation and emission wavelengths of
492 nm and 530 nm, respectively, by using a multiplate reader
(Envision; Perkin–Elmer).
3. Results
3.1. p53 induced Snail degradation
A recent study showed that Snail directly binds to p53 and
modulates its activity In addition, Wang et al. showed that Slug,
a member of the Snail zinc ﬁnger family, is degraded by p53
[16]. Our immunoprecipitation studies with endogenous proteins
also showed that Snail binds to p53 (Fig. 1A). These observations
suggest a relationship between Snail and p53.
To examine this possibility, we performed immunoblot analysis
of Hep3B cells cotransfected with p53 and Snail. HA-Snail protein
levels in the Hep3B cells overexpressing Myc-p53(WT) and HA-
Snail were signiﬁcantly lower than those in the cells transfected
only with HA-Snail (Fig. 1B). However, the HA-Snail protein levels
did not decrease in the cells overexpressing Myc-p53mutant (Mut)
(R249S) and HA-Snail (Fig. 1B). The Snail mRNA levels remained
unchanged under all conditions (Fig. 1C). We performed additional
immunoblot analyses with several p53 point-mutant constructs,
including six hot spot mutants (R175H, R245S, R248W, R249S,
R273H, and R282W) [17] and three mutants identiﬁed through
our sequence analysis (R110L, T155P, and I232S). These mutants
exhibit mutations in the DNA-binding domain (DBD) and showFig. 2. p53 induces the degradation of endogenous Snail protein. (A) Hep3B cells we
puromycin selection, the endogenous Snail and p53 protein levels were analyzed by im
Snail mRNA levels were analyzed by real-time RT-PCR. (C) HepG2 cells were transfected
immunoblotting. (D) MEF cells were obtained from the p53+/+, p53/+, and p53/mice, t
of p53, Snail, and p21.compromised DNA-binding activity [18]. Coexpression assays per-
formed using these DBD point mutants did not show any decrease
in the HA-Snail protein levels (Fig. 1D).
3.2. p53 induced the degradation of endogenous Snail protein
To determine the relationship between p53 and endogenous
Snail expression, we analyzed the changes in Snail expression in
the presence of p53WT/Mut in Hep3B cells (p53-null cell line) by
using a mouse stem cell virus (MSCV) retroviral system to express
p53WT (MSCV-p53WT) and p53Mut (MSCV-p53Mut). Immunoblot
analysis revealed that p53WT inhibited Snail protein levels, but
p53Mut did not (Fig. 2A). Real-time RT-PCR data revealed no
change in Snail mRNA levels in the presence of p53WT (Fig. 2B).
We performed siRNA experiments to check whether endogenous
p53-induced Snail degradation occurred at endogenous protein
levels and found that the endogenous Snail protein levels increased
in HepG2 cells treated with p53 siRNA (Fig. 2C). The MEFs obtained
from the p53+/+, p53+/, and p53/mice were UV-irradiated to in-
duce endogenous p53 expression. In the p53+/+ and p53+/ MEFs,
UV treatment decreased Snail protein levels; however, this effect
was not observed in the p53/ MEFs (Fig. 2D).
3.3. p53 induced Snail degradation via MDM2-mediated
ubiquitination
MDM2 is a p53-dependent E3 ligase [12]. We tested the hypoth-
esis thatMDM2 is the E3 ligase responsible for p53-dependent Snail
degradation. In immunoprecipitation experiments, Flag-Snailre infected with control MSCV, MSCV-p53WT, and MSCV-p53Mut viruses. After
munoblotting with the indicated antibodies. (B) In the same samples, endogenous
with p53 or control siRNA. The expression of p53 and Snail was then assessed by
reated with UV irradiation and then analyzed by immunoblotting for the expression
2234 S.-O. Lim et al. / FEBS Letters 584 (2010) 2231–2236interacted withMDM2 (Fig. 3A). To determine whetherMDM2 pro-
motes Snail ubiquitination, we examined the ubiquitinated Snail in
Hep3B cells cotransfected with Flag-Snail, HA-ubiquitin, and/orFig. 3. p53 induces Snail degradation via MDM2-mediated ubiquitination. (A) Hep3B ce
Flag and anti-MDM2 antibodies, respectively, and analyzed by immunoblotting. IgG ser
and/or MDM2 and immunoprecipitated by anti-Flag antibody. The cell lysates were ana
Fig. 4. MDM2 is associated with Snail degradation. (A) HepG2 cells were transfected with
analyzed by immunoblotting. (B) HepG2 cells were transfected with MDM2 or control si
p53+/+ and p53/ MEFs were treated with UV and/or Nutlin-3. The expression of p53,
control.MDM2. We observed MDM2-dependent Snail ubiquitination in
these cells, and this effect was enhanced by MG132 treatment
(Fig. 3B). In HepG2 cells, the levels of endogenous Snail proteinlls were transfected with Flag-Snail and MDM2, co-immunoprecipitated using anti-
ved as a negative control. (B) Hep3B cells were transfected with Flag-Snail, HA-Ub,
lyzed by immunnoblotting.
MDM2 and treated with/without MG132 for 6 h. MDM2 and Snail expressions were
RNA. The expression of MDM2 and Snail was then analyzed by immunoblotting. (C)
MDM2, and Snail was analyzed by immunoblotting; b-actin served as an internal
S.-O. Lim et al. / FEBS Letters 584 (2010) 2231–2236 2235decreased with MDM2 overexpression – an effect inhibited by
MG132 treatment (Fig. 4A). Although p53WT expression slightly
increased by MDM2 siRNA, the endogenous Snail protein levels in-
creased in HepG2 cells treated with MDM2 siRNA (Fig. 4B). We also
analyzed the endogenous Snail protein levels in the MEFs treated
with Nutlin-3, an MDM2 inhibitor. In the p53+/+ MEFs, UV-induced
p53 expression caused a decrease in the Snail protein levels as
reported above, but the same effect was not observed in the
Nutlin-3-treated cells (Fig. 4C). In the p53/ MEFs, UV treatment,
with or without Nutlin-3, had no effect on the Snail protein
levels (Fig. 4C). These ﬁndings support the conclusion that p53 in-
duces the degradation of Snail protein via MDM2-mediated
ubiquitination.
3.4. p53 regulated invasion via Snail degradation
To determine whether the p53 activities are altered by p53
mutations, we performed proliferation and invasion assays with
MSCV-p53WT, MSCV-p53Mut, and MSCV-Flag-Snail viruses in
the Hep3B cells. Flag-Snail protein levels in the Hep3B cells coin-
fected with MSCV-p53WT and MSCV-Snail were signiﬁcantly low-
er than those in the cells infected with MSCV-Snail alone (Fig. 5A).
However, in the cells coinfected with MSCV-p53Mut and MSCV-
Snail, the Flag-Snail protein levels did not decrease (Fig. 5B). We
performed a CCK-8 assay using the same experimental sample
set and found that the proliferation of the MSCV-p53WT-infected
cells was lower than that of the control MSCV-infected cells how-
ever, the MSCV-p53Mut-infected cells showed increased prolifera-
tion (Fig. 5B). In an invasion assay performed using an Oris™ cellFig. 5. p53 regulates invasion via Snail degradation. Hep3B cells were transfected with M
puromycin. (A) After selection, Myc-p53 and Flag-Snail expression was analyzed by immu
cells was analyzed using the CCK-8 proliferation kit. (C) Cell invasion was analyzed us
determined using the Student’s t-test.invasion kit and Matrigel™ invasion assay, the Snail-infected cells
showed higher invasiveness than the control MSCV-infected cells;
however, the number of invaded p53WT and Snail coinfected cells
was less than that seen in Snail-infected cells (Fig. 5C and S1). In
addition, the cells infected with p53Mut or those coinfected with
p53Mut and Snail showed greater invasiveness (Fig. 5C). These
observations support the hypothesis that p53 inhibits Snail-in-
duced tumor cell invasion via Snail degradation.
4. Discussion
We have shown that p53 has the ability to associate with Snail
and induce its degradation. We also found that p53 induces Snail
degradation via MDM2-mediated ubiquitination. Snail upregulates
EMT and tumor cell invasion in most cancers [6]. The activity and
stability of p53 – a tumor suppressor – is regulated by a complex
network of post-translational modiﬁcations and molecular interac-
tions inﬂuenced by several signaling pathways [11,12]. The role of
K-Ras in the physical interaction between Snail and p53 has also
been recently reported [9]. However, p53-induced Snail degrada-
tion has not been previously reported. Our ﬁndings demonstrate
the physical interactions of p53/Snail and Snail/MDM2 and show
that p53 induces Snail degradation through MDM2-mediated ubiq-
uitination (Fig. 3). These ﬁndings are consistent with those re-
ported by Wang et al. who showed that Slug, a member of the
Snail zinc ﬁnger family, is degraded by p53 [16].
Reactivation of p53WT in tumor cells has been put forth as a po-
tential cancer therapy, thereby stimulating the search for a new
class of reagents with p53-like activity [13]. For example, commonSCV-p53WT, p53Mut, and/or MSCV-Snail, and the transfectants were selected with
noblotting; b-actin served as an internal control. (B) Proliferation of the transfected
ing the Oris™ Cell invasion and detection kit. *, P < 0.05 of three experiments was
2236 S.-O. Lim et al. / FEBS Letters 584 (2010) 2231–2236chemotherapeutic reagents, such as adriamycin or cisplatin, induce
tumor cell apoptosis and increase chemosensitivity via endoge-
nous p53 activation [13,19]. However, in stepwise hepatocarcino-
genesis, the complex micro-environmental changes in the tumor
cells are accompanied by a loss of function or mutation of p53. In
hepatocarcinogenesis, p53 mutation is a late event and occurs in
30% of HCC grade III tissues [20,21]. The reasons for the late occur-
rence of p53 mutation in HCC and the factors or molecular micro-
environmental changes responsible for p53 mutation are yet to be
elucidated. A thorough understanding of p53 molecular mecha-
nisms is required for the development of optimal treatment strat-
egies for HCC.
HCC is known to be highly invasive, and the HCC cells are
known to overexpress Snail proteins [5]; therefore, we utilized
HCC cell lines as a model cell system to study the functional role
of p53 and Snail interaction in disease development. We found that
p53-induced degradation of Snail inhibited Snail-dependent inva-
sive activity. In our experiments, p53Mut could not induce the deg-
radation of Snail protein and did not inhibit tumor cell invasion.
Both Snail overexpression and p53 mutation are typically observed
in grade III HCC tissues [5,20]. Increased p53 levels indicate either
cellular stress or p53 mutation in the tumor cells [22]. We have
previously reported that Snail expression and ROS stress increased
according to the histological grade, particularly in hyperinvasive
grade III tumors [5].
In our invasion assay, p53WT, but not p53Mut, inhibited Snail-
mediated invasion. Overexpression of p53WT in the HCC cells leads
to Snail protein degradation, but Snail is not degraded in the
p53Mut-expressing cells. Snail is overexpressed in the HCC cells
expressing p53Mut, thereby affording highly invasive abilities to
these cells. These observations are consistent with those of grade
III HCCs, which are highly invasive.
In conclusion, we show that p53/Snail interaction induces p53/
MDM2-mediated Snail ubiquitination Snail degradation is depen-
dent on the p53 status, and our results provide evidence for the
integration of p53 and Snail signaling. Regulation of Snail by p53
also causes changes in cellular proliferation and invasion. p53-
mediated modulation of Snail activity has consequences for carci-
nogenesis because both these proteins play a role in invasion and
metastasis. Our ﬁndings also explain the occurrence of hyperinva-
sive cells that carry a p53 gene mutation and exhibit Snail
overexpression.
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